6533b82ffe1ef96bd1295d65

RESEARCH PRODUCT

Gonadal damage and options for fertility preservation in female and male cancer survivors.

Ralf DittrichTheodoros MaltarisMatthias W. BeckmannRudolf SeufertHeinz KoelblAndreas MuellerFranklin Kiesewetter

subject

InfertilityAdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentmedia_common.quotation_subjectFertilityMale infertilityQuality of lifeTesticular NeoplasmsNeoplasmsTestismedicineHumansFertility preservationSurvivorsIntensive care medicineChildmedia_commonGynecologyOvarian NeoplasmsIn vitro fertilisationbusiness.industryOvaryCancerGeneral Medicinemedicine.diseasehumanitiesRadiation therapyFertilityInfertilityFemalebusiness

description

It is estimated that in 2010, 1 in every 250 adults will be a childhood cancer survivor. Today, oncological surgery, radiotherapy and chemotherapy achieve relatively high rates of remission and long-term survival, yet are often detrimental to fertility. Quality of life is increasingly important to long-term survivors of cancer, and one of the major quality-of-life issues is the ability to produce and raise normal children. Developments in the near future in the emerging field of fertility preservation in cancer survivors promise to be very exciting. This article reviews the published literature, discusses the effects of cancer treatment on fertility and presents the options available today thanks to advances in assisted-reproduction technology for maintaining fertility in male and female patients undergoing this type of treatment. The various diagnostic methods of assessing the fertility potential and the efficacy of in vitro fertilization (IVF) after cancer treatment are also presented.

10.1111/j.1745-7262.2006.00206.xhttps://pubmed.ncbi.nlm.nih.gov/16847527